Answers are grounded in this paper and cite their sources.
When deciding whether or not to pool treatment estimates in a meta-analysis, the yard-stick should be the clinical relevance of any heterogeneity present. tau(2), rather than I(2), is the appropriate measure for this purpose.
No takes yet. Share an insight, caveat, or question.
Rücker et al. (2008) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: